Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INBX is expected to report earnings to fall 23.50% to -178 cents per share on November 13

Inhibrx Biosciences INBX Stock Earnings Reports

Q3'26

Est.

$-1.79

Q2'26

Missed

by $0.54

Q1'26

Beat

by $0.08

Q4'25

Missed

by $0.48

Q3'25

Missed

by $0.71

The last earnings report on August 13 showed earnings per share of -233 cents, missing the estimate of -179 cents. With 76.59K shares outstanding, the current market capitalization sits at 1.50B.

View a ticker or compare two or three

INBX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for INBX